Fractyl Health, Inc. (NASDAQ:GUTS) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET
Company Participants
Brian Luque – Head of Investor Relations and Corporate Development
Harith Rajagopalan – Chief Executive Officer
Lisa Davidson – Chief Financial Officer
Conference Call Participants
Mike Ulz – Morgan Stanley
Michael DiFiore – Evercore ISI
William Wood – B. Riley Securities
Operator
Good afternoon, and welcome to Fractyl Health’s Fourth Quarter and Full Year 2024 Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. At this time all participants are in a listen-only mode. There will be a question-and-answer session following management’s prepared remarks.
I will now turn the call over to Brian Luque, Head of Investor Relations and Corporate Development at Fractyl. Brian, you may now begin.
Brian Luque
Thank you. This afternoon, we issued a press release that outlines the topics we plan to discuss today. The release is available at www.fractal.com under the Investors tab. Joining us on the call today are Dr. Harith Rajagopalan, Chief Executive Officer; and Lisa Davidson, Chief Financial Officer.
During this call we make forward-looking statements, which involve risks and uncertainties that may cause actual results to differ materially from our forward-looking statements. We provide a comprehensive list of risk factors in our SEC filings, including the Annual Report on Form 10-K filed today, which I encourage you to review. Any forward-looking statements on the call are subject to substantial risks and uncertainties speak only as of the call’s original date and we undertake no obligation to update or revise any of the statements, even if subsequent events cause the company’s views to change.
It is now my pleasure to pass the call over to Harith.
Harith Rajagopalan
Thank you, Brian, and good afternoon everyone. Thank you for joining us today. GLP-1 drugs
Read the full article here